缺氧 巨细胞衍生的外体 miR-26b-5p 向 PTEN 促进 keloids 的发展
Siya Dai1, Mingyuan Xu1, Qianqian Pang2
1Department of Plastic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Shangcheng District, Hangzhou, China.
Burns & trauma
|March 4, 2024
概括
低毒的巨细胞衍生外体 (HMDE) 通过增强纤维细胞增殖和迁移来促进 keloid 发育. 在HMDE内的外体miR-26b-5p通过PTEN-PI3K/AKT通路驱动这个过程,为 keloid 治疗提供了潜在的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 皮肤病学 皮肤病学
背景情况:
- 状体的特征是缺氧,而巨细胞的表型转变与它们的发展有关.
- 微RNAs (miRNAs) 在异构体中从低氧性巨细胞中对 keloids 的特定作用尚不清楚.
- 这项研究研究了低氧性巨细胞衍生外体 (HMDE) 和它们相关的miRNAs在 keloid 病原发生过程中.
研究的目的:
- 探索HMDE在 keloids 的发生和发展中的作用.
- 在HMDE中识别影响 keloid 进展的关键 miRNA.
- 阐明HMDE介导对质纤维细胞的影响背后的分子机制.
主要方法:
- 免疫光和流动细胞测量以分析大菌偏振在 keloid 组织和低氧条件下.
- 焦显微镜检查证实人体化纤维细胞 (HKFs) 对外体的吸收.
- miRNA测序以识别外体中差异表达的miRNA;双露西法酶记者测试以验证PTEN作为miR-26b-5p的标;功能测试 (CCK-8,伤口愈合,Transwell) 和西斑测试以评估生物功能和信号通路 (PTEN-PI3K/AKT).
主要成果:
- M2类型的巨细胞富含着 keloids,而缺氧会诱导巨细胞偏向到 M2类型.
- 与诺莫克斯外体 (NMDE) 相比,HMDE显著促进HKF的增殖,迁移和入侵.
- 确定了miR-26b-5p作为一种在HMDE中丰富的关键miRNA,转移到HKF中,并通过PTEN-PI3K/AKT通路促进HKF迁移,入侵和扩散.
结论:
- 来自缺氧巨细胞的外体miR-26b-5p显著促进了 keloid 发育.
- PTEN-PI3K/AKT信号通路是miR-26b-5p的前质效应的关键调解者.
- 向外体miR-26b-5p是一个潜在的治疗策略来管理 keloids.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K